Inventor · disambiguated record
Owen Brendan Wallace
Also filed as: WALLACE OWEN B · WALLACE OWEN BRENDAN
35 granted patents·13 pending applications·478 citations·filing 2000–2024
97Inventor score
Files withLILLY CO ELI20FULCRUM THERAPEUTICS INC11BRISTOL MYERS SQUIBB CO6AICHER THOMAS DANIEL2DODGE JEFFREY ALAN2
Top patents by PatentIndex Score
48 records- 0198US6476034B2Antiviral azaindole derivativesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Nov 5, 2002·103 cites·24 claims
- 0295US7037913B2Bicyclo 4.4.0 antiviral derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 2, 2006·60 cites·6 claims
- 0395US6825201B2Indole, azaindole and related heterocyclic amidopiperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 30, 2004·46 cites·6 claims
- 0494US10973805B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 13, 2021·5 cites·20 claims
- 0593US6632819B1Antiviral azaindole derivativesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Oct 14, 2003·38 cites·23 claims
- 0693US6469006B1Antiviral indoleoxoacetyl piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Oct 22, 2002·96 cites·13 claims
- 0791US11590111B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·10 claims
- 0888US10342786B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·4 cites·19 claims
- 0988US6573262B2Composition and antiviral activity of substituted indoleoxoacetic piperazine derivativesBRISTOL MYERS SQIBB COMPANY·Filed 2001·Granted Jun 3, 2003·44 cites·33 claims
- 1087US8217032B2Selective estrogen receptor modulators for the treatment of vasomotor symptomsDALLY ROBERT DEAN·Filed 2011·Granted Jul 10, 2012·15 cites·14 claims
- 1186US10537560B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·4 cites·28 claims
- 1285US6900323B2Antiviral azaindole derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 31, 2005·12 cites·2 claims
- 1384US7968585B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Jun 28, 2011·7 cites·18 claims
- 1483US6967196B1Sulfonamide compounds and uses thereofMERCK & CO INC·Filed 2000·Granted Nov 22, 2005·24 cites·4 claims
- 1583US2025195480A1Macrocyclic azolopyridine derivatives as eed and prc2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1681US12109198B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·5 claims
- 1780US7713979B2Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2005·Granted May 11, 2010·4 cites·7 claims
- 1877US2023257743A1Use of p38 inhibitors to reduce expression of dux4FULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1975US7998999B2Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Aug 16, 2011·3 cites·14 claims
- 2075US7994176B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Aug 9, 2011·2 cites·21 claims
- 2175US2022282254A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2272US2022133704A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2370US11479770B2Use of p38 inhibitors to reduce expression of DUX4FULCRUM THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·8 claims
- 2470US7829582B2Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Nov 9, 2010·1 cites·21 claims
- 2570US6962928B2Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosisLILLY CO ELI·Filed 2002·Granted Nov 8, 2005·4 cites·32 claims
- 2669US7816349B2Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Oct 19, 2010·1 cites·16 claims
- 2767US11291659B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·0 cites·15 claims
- 2867US7820659B2Cyclohexylimidiazole lactam derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Oct 26, 2010·1 cites·20 claims
- 2966US7119206B2Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulatorsLILLY CO ELI·Filed 2003·Granted Oct 10, 2006·2 cites·15 claims
- 3059US7375229B2Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methodsLILLY CO ELI·Filed 2006·Granted May 20, 2008·0 cites·3 claims
- 3154US7585977B2Selective estrogen receptor modulators containing a phenylsulfonyl groupLILLY CO ELI·Filed 2008·Granted Sep 8, 2009·0 cites·18 claims
- 3254US7067510B2Dihydro-dibenzo[b,e]oxepine based selective estrogren receptor modulators, compositions and methodsLILLY CO ELI·Filed 2003·Granted Jun 27, 2006·0 cites·18 claims
- 3349US2009023917A1Selective Estrogen Receptor Modulators for the Treatment of Vasomotor SymptomsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 3446US8148534B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LI RENHUA·Filed 2007·Granted Apr 3, 2012·0 cites·10 claims
- 3546US7271264B2Pentacyclic oxepines and derivatives thereof, compositions and methodsLILLY CO ELI·Filed 2003·Granted Sep 18, 2007·0 cites·34 claims
- 3646US2004152733A1Duloxetine for treatment of hot flashesFiled 2002·Application pending·0 cites
- 3745US7981918B2Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2007·Granted Jul 19, 2011·0 cites·20 claims
- 3844US8088776B2Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1AICHER THOMAS DANIEL·Filed 2007·Granted Jan 3, 2012·0 cites·20 claims
- 3944US7834194B2Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2005·Granted Nov 16, 2010·0 cites·4 claims
- 4043US8153807B2Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1BUSH JULIE KAY·Filed 2007·Granted Apr 10, 2012·0 cites·22 claims
- 4143US7056931B22-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methodsLILLY CO ELI·Filed 2002·Granted Jun 6, 2006·0 cites·32 claims
- 4243US2007015786A1Treatment of hot flashes, impulse control disorders and personality change due to a general medical conditionLILLY CO ELI·Filed 2004·Application pending·0 cites
- 4343US2007111988A1Selective estrogen receptor modulatorsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 4443US2010184764A1Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2010·Application pending·0 cites
- 4539US2008214621A1Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1AICHER THOMAS DANIEL·Filed 2005·Application pending·0 cites
- 4639US2002061892A1Antiviral azaindole derivativesFiled 2001·Application pending·0 cites
- 4734US2008227814A1Selective Estrogen Receptor ModulatorsDODGE JEFFREY ALAN·Filed 2005·Application pending·0 cites
- 4832US2008221163A1Selective Estrogen Receptor ModulatorsDODGE JEFFREY ALAN·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →